[The fibrinolysis system in diabetic glomerulosclerosis].
It was found that patients with diabetic glomerulosclerosis showed an increased intensity of blood coagulation as well as essential diverse changes in the system of fibrinolysis. These changes were more pronounced in patients suffering of diabetes mellitus than in the diabetic patients without glomerulosclerosis. It is recommended to introduce into clinical practice the Lejen method with the purpose of determining indications to heparin therapy and dynamic control of patients during treatment with anticoagulants.
Lapchinskaia
I I
II
D000293:Adolescent; D000328:Adult; D002908:Chronic Disease; D003327:Coronary Disease / Q000097:blood; D003925:Diabetic Angiopathies / Q000097:blood; D003928:Diabetic Nephropathies / Q000097:blood*; D003930:Diabetic Retinopathy / Q000097:blood; D005260:Female; D005342:Fibrinolysis; D005923:Glomerulosclerosis, Focal Segmental / Q000097:blood*; D005951:Glucose Tolerance Test; D006801:Humans; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000097:blood
Sistema fibrinoliza pri diabeticheskom glomeruloskleroze.